We are pleased to advise that our first site in South Korea, Samsung Medical Center, has commenced patient recruitment! All patients diagnosed with multiple myeloma or a related disease from this hospital will be invited to participate in the Registry.
Samsung Medical Center is one of eight South Korean hospitals confirmed to participate in the APAC MRDR. Further sites will open and commence recruitment when they obtain the necessary approvals.
We are grateful for the efforts of the research team at Samsung Medical Center and look forward to seeing the results of the study at this site.